Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2013
06/05/2013CN103127119A Pharmaceutical composition of piribedil/folic acid compound and purpose thereof
06/05/2013CN103127118A Medicine composition of pramipexole/ folic acid compounds and functions thereof
06/05/2013CN103127117A Pharmaceutical composition of levodopa/benserazide/folic acid compounds and purpose thereof
06/05/2013CN103127116A Carbidopa/levodopa/folic acid compound medicine composition and use thereof
06/05/2013CN103127105A Rhynchophylline application in drug preparing for preventing inflammation caused by excessive activation of astrocytes
06/05/2013CN103127071A Application of Eryngiolide A in medicines curing Alzheimer disease
06/05/2013CN103127059A Oral administration preparation composed of bilobalide B derivative and preparation method thereof
06/05/2013CN103127046A Medicine containing diacetyl rhein compound and preparation method of medicine
06/05/2013CN103127045A Composition containing gamma-aminobutyric acid and lycopene and preparation method thereof
06/05/2013CN103127024A Stable disodium adenosine triphosphate tablet
06/05/2013CN103127023A Duloxetine hydrochloride enteric-coated tablet and preparation method
06/05/2013CN103127005A Preparation method of novel dopamine brain-targeting nano-particles
06/05/2013CN103126997A Sustained release microsphere containing risperidone and risperidone analogues and preparation method thereof
06/05/2013CN103126980A Gastrodin injection preparation and preparation method
06/05/2013CN103126971A Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins
06/05/2013CN103125928A Preparation method of gastrodia elata essence
06/05/2013CN103125627A Smoking cessation tea
06/05/2013CN102579852B Medicament for treating peripherical facial paralysis
06/05/2013CN102552666B Chinese lavipeditum composition for treating insomnia
06/05/2013CN102441103B Medicine for treating insomnia
06/05/2013CN102440956B Preparation method of self-emulsified sumatriptan and salt preparation thereof
06/05/2013CN102416012B Pharmaceutical composition for treating children's hyperactivity
06/05/2013CN102370635B Application and preparation method of novel nardosinone
06/05/2013CN102349907B Medicament for treating schizophrenia comprising cilostazol
06/05/2013CN102344408B Double-effect anesthetic
06/05/2013CN102337266B siRNAs and recombinant vector for inhibiting expression of Nogo A, MAG and OMgp genes, and application of siRNAs and recombinant vector
06/05/2013CN102335386B Chinese medicinal composition for dispersing qi depression, promoting appetite, removing stagnation and stopping pain and preparation method thereof
06/05/2013CN102309528B Preparation method of active substance capable of resisting neurodegenerative disease
06/05/2013CN102266503B Sugar-free anemopyretic cold granules and preparation method thereof
06/05/2013CN102258753B Chinese medicinal composition for treating poststroke depression and preparation method thereof
06/05/2013CN102250048B 2-phenylselenomethyl-2,3-dihydrobenzofuran and preparation and application thereof
06/05/2013CN102232953B Medicinal composition containing Esopiclone and preparation method thereof
06/05/2013CN102106826B Aripiprazole solid preparation and preparation method thereof
06/05/2013CN102106808B Solid preparation and preparation method thereof
06/05/2013CN102083832B Spiro (piperidine-4,2'-pyrrolidine)-1-(3,5-trifluoromethyl phenyl) methylcarboxamides as NK1 Tachikynin receptor antagonists
06/05/2013CN101991612B Preparation method of haematococcus pluvialis extracts
06/05/2013CN101978990B Schisandra extract and preparation method and application thereof
06/05/2013CN101967168B Triterpenoid saponin derivative and preparation method and application thereof
06/05/2013CN101906104B 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
06/05/2013CN101905015B Medicine capable of decomposing alcohol, preventing drunkenness and protecting liver
06/05/2013CN101857591B Hydrochloric acid tiagabine crystal formations and preparation method thereof
06/05/2013CN101802174B Cell growth method and pharmaceutical preparation for tissue repair and regeneration
06/05/2013CN101780097B Application of DGPP (diacylglycerol pyrophosphate) in preparation of medicines for treating ischemic heart disease
06/05/2013CN101711240B Sleep-improving agent
06/05/2013CN101646351B Process of producing tomato paste
06/05/2013CN101583601B Isoquinolone compounds as subtype-selective agonists for melatonin receptors mt1 and mt2
06/05/2013CN101535289B Novel phenylacetic acid derivative
06/05/2013CN101496854B Chinese medicine sobering-up composition and Chinese medicine sobering-up beverage
06/05/2013CN101460624B Sense oligonucleotide capable of controlling the expression of iNOS and composition comprising the same
06/05/2013CN101433565B Total alkaloid extract of seeds of harmel genus, and preparation thereof
06/05/2013CN101352509B Velvet deerhorn liquor and preparation method thereof
06/05/2013CN101244154B Pharmaceutical combination for bearing and rearing better children, preventing birth defect and improving anamnesis
06/05/2013CN101194965B Mastication tablet for treating headache and method for preparing the same
06/05/2013CN101194963B Process for preparing medicine for treating headache
06/05/2013CN101194961B Aerosol for treating headache and method for preparing the same
06/05/2013CN101194959B Capsule for treating headache and method for preparing the same
06/05/2013CN101194945B Tablet for treating headache and method for preparing the same
06/05/2013CN101141964B Methods and compositions for treating diabetes, metabolic syndrome and other conditions
06/04/2013US8455550 Derivatives of aminocyclobutane or aminocyclobutene, their method of preparation and their use as medical products
06/04/2013US8455536 Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione
06/04/2013US8455511 Pyrrolopyridine derivatives substituted with cyclic amino group
06/04/2013US8455502 Selective phosphodiesterase 9A inhibitors as medicaments for improving cognitive processes
06/04/2013US8455498 Inhibitors of histone deacetylase
06/04/2013US8455489 Substituted pyrimidine compositions and methods of use
06/04/2013US8455445 Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated disorders
06/04/2013CA2542419C Use of glutamyl cyclase inhibitors in the treatment of familial british dementia and familial danish dementia
06/04/2013CA2534885C 2-(quinoxalin-5-ylsulfonylamino)-benzamide compounds as cck2 modulators
06/04/2013CA2457801C Streptococcus thermophilus strain and use thereof
06/02/2013CA2761068A1 Novel dosage regimens and methods for treatment, prevention, and/or management of at least one cns disorder
05/2013
05/30/2013WO2013078395A1 L-serine compositions, methods and uses for treating neurodegenerative diseases and disorders
05/30/2013WO2013078385A1 Methods of increasing neuronal differentiation using antibodies to lysophosphatidic acid
05/30/2013WO2013078123A1 Heterocyclic inhibitors of glutaminase
05/30/2013WO2013077851A1 Immediate release abuse deterrent tablet
05/30/2013WO2013076646A1 A new diaza-benzofluoranthene derivative as drug
05/30/2013WO2013076516A1 1,4- dihydropyridine derivatives with hsp modulating activity
05/30/2013WO2013076331A1 Phosphorylation on the thr-248 and/or thr-250 residues of transcription factor e2f4 as a therapeutic target in pathological processes associated with somatic polyploidy
05/30/2013WO2013076101A1 Lactoferrin and the white matter
05/30/2013WO2013075823A1 Transdermal therapeutic system comprising rotigotine and crystallization inhibitor
05/30/2013WO2013075822A1 Transdermal therapeutic system (tts) with rotigotine
05/30/2013WO2013075624A1 Glycine reuptake inhibitor and use thereof
05/30/2013WO2013075621A1 Norepinephrine and selective serotonin receptor blocker and use thereof
05/30/2013WO2013075459A1 Use of levo-oxiracetam and oxiracetam in preparation of medicines for preventing or treating coma
05/30/2013WO2013075227A1 β-GLUCOCEREBROSIDASE CHAPERONES
05/30/2013WO2013054110A3 Compositions for binding to amyloid proteins
05/30/2013WO2013034982A3 Immunomodulatory peptides for treatment of progressive neurodegenerative diseases
05/30/2013US20130137727 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
05/30/2013US20130136798 Novel parenteral controlled release formulations of nsaid's
05/30/2013US20130136775 Hydrophobic drug-delivery material, method for manufacturing thereof and methods for delivery of a drug-delivery composition
05/30/2013US20130136747 Anti-amyloid beta antibodies and their use
05/30/2013CA2856386A1 Heterocyclic inhibitors of glutaminase
05/30/2013CA2855854A1 L-serine compositions, methods and uses for treating neurodegenerative diseases and disorders
05/30/2013CA2854252A1 1,4-dihydropyridine derivatives with hsp modulating activity
05/30/2013CA2853764A1 Immediate release abuse deterrent tablet
05/29/2013EP2597088A1 P2x4 receptor antagonist
05/29/2013EP2597084A1 N-hydroxyformamide derivative and pharmaceutical containing same
05/29/2013EP2596021A2 A method of treating alzheimer's disease
05/29/2013EP2596020A2 Method of treatment of organic diseases of nervous system, psychoorganic syndrome and encephalopathy
05/29/2013EP2596019A2 A method of treating attention deficit hyperactivity disorder
05/29/2013EP2596018A2 Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia
05/29/2013EP2595993A2 Tricyclic proteasome activity enhancing compounds